What is the definition of Chromophobe Renal Cell Carcinoma?

Chromophobe renal cell carcinoma is a rare subtype of the most common form of kidney cancer called renal cell carcinoma (RCC). This type of cancer forms in the cells lining the small tubules in the kidney. These tubules help filter waste from the blood, making urine. Chromophobe RCC accounts for about 5% of all RCC cases, and it is frequently diagnosed between ages 40 and 50. It is typically diagnosed in stage I or stage II, and has an overall better prognosis than other types of RCC. Treatment generally involves surgery.

What are the alternative names for Chromophobe Renal Cell Carcinoma?

  • CRCC
  • ChRCC
  • Condition: Kidney Cancer
  • Journal: The New England journal of medicine
  • Treatment Used: Pembrolizumab
  • Number of Patients: 496
  • Published —
The study researched the use of pembrolizumab for treating patients with kidney cancer.
  • Condition: Patients with Metastatic Renal Cell Cancer (mRCC) in Finland
  • Journal: World journal of surgical oncology
  • Treatment Used: Cytoreductive Nephrectomy (CN)
  • Number of Patients: 732
  • Published —
This study evaluated the survival effects of cytoreductive nephrectomy (CN) in patients with metastatic renal cell cancer (mRCC) in Finland.
Clinical Trial
  • Status: Active, not recruiting
  • Phase: Phase 2
  • Intervention Type: Drug
  • Participants: 730
  • Start Date: January 2016
A Phase II Safety Trial of Nivolumab in Patients With Metastatic Renal Cell Carcinoma Who Have Progresses During or After Prior Systemic Anti-angiogenic Regimen
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 2
  • Intervention Type: Drug
  • Participants: 77
  • Start Date: November 29, 2019
CABRAMET: A Phase 2 Study of Cabozantinib in Metastatic Renal Cell Carcinoma (mRCC) With Brain Metastases